IV 
118TH CONGRESS 
1ST SESSION 
H. RES. 217 
Supporting the designation of March 2023 as Endometriosis Awareness 
Month. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 9, 2023 
Mr. DAVID SCOTT of Georgia (for himself, Mrs. GONZA´LEZ-COLO´N, Ms. WIL-
LIAMS of Georgia, Ms. NORTON, Mrs. WATSON COLEMAN, Ms. LOIS 
FRANKEL of Florida, Ms. CHU, Mrs. DINGELL, Mr. PANETTA, Ms. 
TLAIB, Mr. BISHOP of Georgia, Mr. CARTER of Louisiana, Mr. PETERS, 
Ms. STEVENS, Ms. VELA´ZQUEZ, Ms. JACKSON LEE, and Mr. ESPAILLAT) 
submitted the following resolution; which was referred to the Committee 
on Energy and Commerce 
RESOLUTION 
Supporting the designation of March 2023 as Endometriosis 
Awareness Month. 
Whereas endometriosis is a disease in which the type of tis-
sue that normally grows in the uterus (the endometrium) 
also grows outside of the uterus; 
Whereas endometriosis is one of the most common gyneco-
logical diseases in women, and occurs in 1 in 10 women 
of reproductive age; 
Whereas the cause of endometriosis is not known, but risk 
factors include— 
VerDate Sep 11 2014 
01:43 Mar 10, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR217.IH
HR217
kjohnson on DSK79L0C42PROD with BILLS
•HRES 217 IH 
(1) having a mother, sister, or daughter with endo-
metriosis; 
(2) menstrual cycles that started at an early age; 
(3) menstrual cycles that are short; and 
(4) periods that are heavy and last more than 7 
days; 
Whereas, for many women, the only way currently available 
to be certain of an endometriosis diagnosis is to have a 
surgical procedure known as a laparoscopy; 
Whereas endometriosis primarily affects women in their 30s 
and 40s, but can affect any woman who menstruates; 
Whereas women experience a delay from three to eleven years 
between the first symptoms of pain and the final endo-
metriosis diagnosis, which can lead to lower quality of life 
and high medical costs; 
Whereas for many girls and women, endometriosis is a life-
long chronic disease that can affect relationships, school, 
work, fertility, and daily life; 
Whereas the primary symptoms of endometriosis include pain 
and infertility, and many with endometriosis live with de-
bilitating, chronic pain; 
Whereas approximately 75 percent of women with endo-
metriosis experience a misdiagnosis; 
Whereas the management of symptoms of endometriosis may 
include low-dose oral contraceptives, intrauterine devices 
(IUDs), painkillers, including nonsteroidal anti-inflam-
matory drugs (NSAIDs), and gonadotropin-releasing hor-
mone (GnRH) agonist therapy; 
Whereas endometriosis is associated with increased health 
care costs and poses a substantial burden to patients in 
the health care system; 
VerDate Sep 11 2014 
01:43 Mar 10, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR217.IH
HR217
kjohnson on DSK79L0C42PROD with BILLS
•HRES 217 IH 
Whereas, in the United States, the estimated average direct 
health care cost associated with endometriosis per patient 
is more than $13,000 per year; 
Whereas 40 percent of women with endometriosis report im-
paired career growth due to endometriosis, and approxi-
mately 50 percent of women with endometriosis experi-
ence a decreased ability to work; 
Whereas the Centers for Disease Control and Prevention 
found that the average number of ‘‘bed days’’ for pa-
tients with endometriosis was 18 days per year; 
Whereas women with endometriosis can lose 11 hours per 
workweek through lost productivity; 
Whereas the physical and psychological impact of endo-
metriosis affects all domains of life, including social life, 
relationships, and work; 
Whereas medical societies and patient groups have expressed 
the need for greater public attention and updated re-
sources targeted to public education about this unmet 
health need for women; 
Whereas there is a need for more research and updated 
guidelines to treat endometriosis; 
Whereas there is an ongoing need for additional clinical re-
search and treatment options to manage this debilitating 
disease; and 
Whereas there is no known cure for endometriosis: Now, 
therefore, be it 
Resolved, That the House of Representatives— 
(1) strongly supports the goals and ideals of 
Endometriosis Awareness Month; 
VerDate Sep 11 2014 
01:43 Mar 10, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR217.IH
HR217
kjohnson on DSK79L0C42PROD with BILLS
•HRES 217 IH 
(2) recognizes the need for early detection and 
treatment of endometriosis, increased education for 
health care providers, and more culturally competent 
care; 
(3) remains committed to supporting and fund-
ing endometriosis research for more effective treat-
ments, increasing fertility, and, ultimately, a cure; 
and 
(4) encourages the people of the United States 
to observe the month with appropriate awareness 
and educational activities. 
Æ 
VerDate Sep 11 2014 
01:43 Mar 10, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR217.IH
HR217
kjohnson on DSK79L0C42PROD with BILLS